249 related articles for article (PubMed ID: 26777686)
1. [Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment].
Neuzillet Y; Colin P; Comperat E; Dubosq F; Houede N; Larre S; Masson-Lecomte A; Pignot G; Puech P; Roumiguie M; Xylinas E; Mejean A; Roupret M
Prog Urol; 2016 Mar; 26(3):181-90. PubMed ID: 26777686
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of non-muscle invasive bladder tumours by instillations of mitomycin C and BCG: a survey on French urologists by the French Urological Association].
Descazeaud A; Mignard JP; Davin JL; Irani J
Prog Urol; 2009 Oct; 19(9):624-31. PubMed ID: 19800553
[TBL] [Abstract][Full Text] [Related]
3. [Single, immediate postoperative intra-vesical instillation (SI) compared to a single preoperative intra-vesical instillation of mitomycin C in non-muscle invasive bladder cancer (NMIBC). Phase II randomized trial].
Breton J; Bernardeau S; Vallée M; Pillot P; Lebacle C; Delpech PO; Charles T; Biscans C; Vallat A; Pfister C; Irani J
Prog Urol; 2021 Feb; 31(2):63-70. PubMed ID: 32891506
[TBL] [Abstract][Full Text] [Related]
4. Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey.
Nielsen ME; Smith AB; Pruthi RS; Guzzo TJ; Amiel G; Shore N; Lotan Y
BJU Int; 2012 Oct; 110(7):967-72. PubMed ID: 22487336
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of the optimization of the conditions of mitomycin C intravesical instillation completion in the setting of non-muscle invasive bladder cancer treatment].
Lailler G; Neuzillet Y; Rouanne M; Lebret T
Prog Urol; 2016 Feb; 26(2):79-82. PubMed ID: 26653577
[TBL] [Abstract][Full Text] [Related]
6. [Intravesical adjuvant regimen of epitubicin for intermediate risk NMIBC: Feasability study from CC-AFU vessie].
Rollin P; Xylinas E; Lanz C; Audenet F; Brunelle S; Compérat E; Houédé N; Larré S; Masson-Lecomte A; Pignot G; Roumiguié M; Méjean A; Rouprêt M; Neuzillet Y;
Prog Urol; 2022 Apr; 32(5):326-331. PubMed ID: 35151544
[TBL] [Abstract][Full Text] [Related]
7. [Guidelines for good practice of intravesical instillations of BCG and mitomycin C from the French national cancer committee (CC-AFU) for non-muscle invasive bladder cancer].
Rouprêt M; Neuzillet Y; Larré S; Pignot G; Coloby P; Rébillard X; Mongiat-Artus P; Chartier-Kastler E; Soulié M; Pfister C;
Prog Urol; 2012 Nov; 22(15):920-31. PubMed ID: 23102014
[TBL] [Abstract][Full Text] [Related]
8. [Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer].
Leon P; Saint F; Audenet F; Roumiguié M; Allory Y; Loriot Y; Masson-Lecomte A; Pradère B; Seisen T; Traxer O; Xylinas E; Roupret M; Neuzillet Y
Prog Urol; 2022 Apr; 32(5):299-311. PubMed ID: 35151545
[TBL] [Abstract][Full Text] [Related]
9. The use of immediate postoperative instillations of intravesical chemotherapy after TURBT of NMIBC among European countries.
Palou-Redorta J; Rouprêt M; Gallagher JR; Heap K; Corbell C; Schwartz B
World J Urol; 2014 Apr; 32(2):525-30. PubMed ID: 23907663
[TBL] [Abstract][Full Text] [Related]
10. National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancer.
Cookson MS; Chang SS; Oefelein MG; Gallagher JR; Schwartz B; Heap K
J Urol; 2012 May; 187(5):1571-6. PubMed ID: 22425105
[TBL] [Abstract][Full Text] [Related]
11. Chemo-prevention in superficial bladder cancer using mitomycin C: a survey of the practice patterns of British urologists.
Clarke NS; Basu S; Prescott S; Puri R
BJU Int; 2006 Apr; 97(4):716-9. PubMed ID: 16536760
[TBL] [Abstract][Full Text] [Related]
12. Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey.
Hendricksen K; Aziz A; Bes P; Chun FK; Dobruch J; Kluth LA; Gontero P; Necchi A; Noon AP; van Rhijn BWG; Rink M; Roghmann F; Rouprêt M; Seiler R; Shariat SF; Qvick B; Babjuk M; Xylinas E;
Eur Urol Focus; 2019 Jul; 5(4):681-688. PubMed ID: 29074050
[TBL] [Abstract][Full Text] [Related]
13. Are we following the guidelines on non-muscle invasive bladder cancer?
Reis LO; Moro JC; Ribeiro LF; Voris BR; Sadi MV
Int Braz J Urol; 2016; 42(1):22-8. PubMed ID: 27136464
[TBL] [Abstract][Full Text] [Related]
14. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and management of adverse events occuring during BCG therapy for non-muscle invasive bladder cancer (NMIBC): review of the Cancer Committee of the French Association of Urology].
Neuzillet Y; Rouprêt M; Wallerand H; Pignot G; Larré S; Irani J; Davin JL; Moreau JL; Soulié M; Pfister C;
Prog Urol; 2012 Dec; 22(16):989-98. PubMed ID: 23178094
[TBL] [Abstract][Full Text] [Related]
16. [Management of non invasive bladder cancers. T1Ga urothelial cell carcinoma: benefit of immediate post operative instillation?].
Rouprêt M; Guillotreau J; Irani J; Zerbib M
Prog Urol; 2010 Mar; 20 Suppl 1():S46-9. PubMed ID: 20493444
[TBL] [Abstract][Full Text] [Related]
17. An immediate, single intravesical instillation of mitomycin C is of benefit in patients with non-muscle-invasive bladder cancer irrespective of prognostic risk groups.
Bosschieter J; Nieuwenhuijzen JA; Vis AN; van Ginkel T; Lissenberg-Witte BI; Beckers GMA; van Moorselaar RJA
Urol Oncol; 2018 Sep; 36(9):400.e7-400.e14. PubMed ID: 30064935
[TBL] [Abstract][Full Text] [Related]
18. Single instillation of mitomycin C plus bacillus Calmette-Guérin (BCG) versus BCG alone in high grade non-muscle invasive bladder cancer.
Weiss BE; Pietzak EJ; Wein AJ; Malkowicz SB; Guzzo TJ
Can J Urol; 2015 Aug; 22(4):7876-81. PubMed ID: 26267025
[TBL] [Abstract][Full Text] [Related]
19. Practice pattern of non-muscle invasive bladder cancer in Japan, Korea and Taiwan: A Web-based survey.
Choo SH; Nishiyama H; Kitamura H; Chen CH; Pu YS; Lee HL; Jeong BC; Kim SI
Int J Urol; 2019 Dec; 26(12):1121-1127. PubMed ID: 31512280
[TBL] [Abstract][Full Text] [Related]
20. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
Steinbach F; Schuster F
Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
